These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27152851)

  • 1. Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer.
    Chin RI; Spencer CR; DeWees T; Hwang MY; Patel P; Sinha P; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Lewis JS; Thorstad WL
    Head Neck; 2016 Nov; 38(11):1643-1649. PubMed ID: 27152851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
    Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
    Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status.
    Molony P; Kharytaniuk N; Boyle S; Woods RSR; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    Head Neck; 2017 Aug; 39(8):1680-1688. PubMed ID: 28560813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
    Bar-Ad V; Wang ZX; Leiby B; Tuluc M
    J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
    Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
    Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
    Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracapsular extension is associated with worse distant control and progression-free survival in patients with lymph node-positive human papillomavirus-related oropharyngeal carcinoma.
    Shevach J; Bossert A; Bakst RL; Liu J; Misiukiewicz K; Beyda J; Miles BA; Genden E; Posner MR; Gupta V
    Oral Oncol; 2017 Nov; 74():56-61. PubMed ID: 29103752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
    Tatebe H; Doi H; Ishikawa K; Kawakami H; Yokokawa M; Nakamatsu K; Kanamori S; Shibata T; Kitano M; Nishimura Y
    Anticancer Res; 2018 Feb; 38(2):979-986. PubMed ID: 29374730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for preoperative prediction of nodal extracapsular extension or positive surgical margins in oropharyngeal squamous cell carcinoma.
    Hararah MK; Stokes WA; Jones BL; Oweida A; Ding D; McDermott J; Goddard J; Karam SD
    Oral Oncol; 2018 Aug; 83():73-80. PubMed ID: 30098782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
    Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Townsend M; DeWees T; Gross J; Daly M; Gay H; Thorstad W; Jackson RS
    Otolaryngol Head Neck Surg; 2019 Aug; 161(2):297-306. PubMed ID: 31159646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma.
    Pasalic D; Funk RK; García JJ; Price DL; Price KA; Harmsen WS; Patel SH; Young GD; Foote RL; Moore EJ; Ma DJ
    Oral Oncol; 2018 Jul; 82():181-186. PubMed ID: 29909895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
    Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
    Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.